Home › NDC Lookup › RxCUI directory › RxCUI 834243

Febuxostat 80 MG Oral Tablet [Uloric] — RxCUI 834243

RxNorm drug concept · Semantic branded drug
RxCUI 834243 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 8 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI834243
Official nameFebuxostat 80 MG Oral Tablet [Uloric]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asUloric 80 MG Oral Tablet
FDA products mapped2
Package NDCs mapped8
Reported Medicaid activity (SDUD)308 prescriptions · 4 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Febuxostat: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It lowers uric acid in adults with gout. It's meant for people who didn't respond to allopurinol, can't tolerate it, or can't use it. It isn't recommended if you have high uric aci...
  • Take it by mouth once a day, with or without food or antacids. Your prescriber may adjust the dose after a couple of weeks based on your uric acid level. Follow your label closely.
  • As uric acid drops, urate stored in your tissues is released, and that can trigger flares. It's common early on. Your doctor will likely recommend an NSAID or colchicine to help pr...
  • Why did my gout flare up after I started?
📖 Read our full Febuxostat guide →

🕸️ Concept Web — How Febuxostat 80 MG Oral Tablet [Uloric] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Febuxostat 80 MG Oral Tablet [Uloric] RxCUI 834243

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Febuxostat 73689
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Uloric 834236
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Febuxostat Oral Tablet 834234
    • Febuxostat Oral Product 1163807
    • Febuxostat Pill 1163808
    • Febuxostat Oral Tablet [Uloric] 834238
    • Uloric Oral Product 1187686
    • Uloric Pill 1187687
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Febuxostat 80 MG Oral Tablet SCD · 834241
  • Febuxostat 80 MG SCDC · 834240
  • Febuxostat Oral Tablet SCDF · 834234
  • Febuxostat Oral Product SCDG · 1163807
  • Febuxostat Pill SCDG · 1163808

Brand-Name Concepts

  • Febuxostat 80 MG [Uloric] SBDC · 834242
  • Febuxostat Oral Tablet [Uloric] SBDF · 834238
  • Uloric Oral Product SBDG · 1187686
  • Uloric Pill SBDG · 1187687
  • Uloric BN · 834236

📦 FDA Products & Package NDCs

2 products · 8 package NDCs
8 package NDCs map to RxCUI 834243 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
64764-0677-11 10 BLISTER PACK in 1 CARTON (64764-677-11) / 10 TABLET in 1... ULORIC Takeda Pharmaceuticals America, Inc. 2009-02-13
64764-0677-13 100 TABLET in 1 BOTTLE (64764-677-13) ULORIC Takeda Pharmaceuticals America, Inc. 2009-02-13
64764-0677-19 1000 TABLET in 1 BOTTLE (64764-677-19) ULORIC Takeda Pharmaceuticals America, Inc. 2009-02-13
64764-0677-30 30 TABLET in 1 BOTTLE (64764-677-30) ULORIC Takeda Pharmaceuticals America, Inc. 2009-02-13
64764-0918-11 10 BLISTER PACK in 1 CARTON (64764-918-11) / 10 TABLET in 1... ULORIC Takeda Pharmaceuticals America, Inc. 2009-02-13
64764-0918-18 500 TABLET in 1 BOTTLE (64764-918-18) ULORIC Takeda Pharmaceuticals America, Inc. 2009-02-13
64764-0918-30 30 TABLET in 1 BOTTLE (64764-918-30) ULORIC Takeda Pharmaceuticals America, Inc. 2009-02-13
64764-0918-90 90 TABLET in 1 BOTTLE (64764-918-90) ULORIC Takeda Pharmaceuticals America, Inc. 2009-02-13
Observed labelers: Takeda Pharmaceuticals America, Inc. (8) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.